• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Earnings Scheduled For March 1, 2022

    3/1/22 4:24:59 AM ET
    $ADT
    $ADV
    $AGEN
    $AIV
    Diversified Commercial Services
    Consumer Discretionary
    Real Estate
    Real Estate
    Get the next $ADT alert in real time by email

     

    Companies Reporting Before The Bell

    • Precigen (NASDAQ:PGEN) is expected to report earnings for its fourth quarter.

    • TG Therapeutics (NASDAQ:TGTX) is estimated to report quarterly loss at $0.63 per share on revenue of $6.74 million.

    • Quanterix (NASDAQ:QTRX) is likely to report quarterly loss at $0.66 per share on revenue of $28.49 million.

    • Paya Holdings (NASDAQ:PAYA) is expected to report quarterly earnings at $0.08 per share on revenue of $63.99 million.

    • APi Gr (NYSE:APG) is likely to report quarterly earnings at $0.26 per share on revenue of $959.69 million.

    • Pieris Pharmaceuticals (NASDAQ:PIRS) is likely to report quarterly loss at $0.30 per share on revenue of $2.45 million.

    • Forma Therapeutics Hldgs (NASDAQ:FMTX) is likely to report earnings for its fourth quarter.

    • Cronos Group (NASDAQ:CRON) is projected to report quarterly loss at $0.15 per share on revenue of $29.97 million.

    • RadNet (NASDAQ:RDNT) is estimated to report quarterly earnings at $0.19 per share on revenue of $348.34 million.

    • Hostess Brands (NASDAQ:TWNK) is likely to report quarterly earnings at $0.23 per share on revenue of $281.74 million.

    • Kohl's (NYSE:KSS) is expected to report quarterly earnings at $2.12 per share on revenue of $6.54 billion.

    • AutoZone (NYSE:AZO) is likely to report quarterly earnings at $17.79 per share on revenue of $3.17 billion.

    • Bank of Nova Scotia (NYSE:BNS) is projected to report quarterly earnings at $1.60 per share on revenue of $6.17 billion.

    • Bank of Montreal (NYSE:BMO) is estimated to report quarterly earnings at $2.56 per share on revenue of $5.21 billion.

    • Hormel Foods (NYSE:HRL) is likely to report quarterly earnings at $0.44 per share on revenue of $2.93 billion.

    • Baidu (NASDAQ:BIDU) is likely to report quarterly earnings at $1.38 per share on revenue of $5.09 billion.

    • Melco Resorts and Enter (NASDAQ:MLCO) is expected to report earnings for its fourth quarter.

    • P10 (NYSE:PX) is expected to report quarterly earnings at $0.16 per share on revenue of $43.98 million.

    • Arbe Robotics (NASDAQ:ARBE) is likely to report quarterly loss at $0.10 per share on revenue of $4.00 million.

    • Thoughtworks Holding (NASDAQ:TWKS) is likely to report quarterly earnings at $0.09 per share on revenue of $286.47 million.

    • Lilium (NASDAQ:LILM) is expected to report earnings for its fourth quarter.

    • Outbrain (NASDAQ:OB) is estimated to report quarterly earnings at $0.20 per share on revenue of $283.90 million.

    • CCC Intelligent Solutions (NYSE:CCCS) is expected to report quarterly earnings at $0.06 per share on revenue of $182.42 million.

    • Full Truck Alliance Co (NYSE:YMM) is projected to report earnings for its fourth quarter.

    • Cerevel Therapeutics Hldg (NASDAQ:CERE) is estimated to report earnings for its fourth quarter.

    • New Fortress Energy (NASDAQ:NFE) is projected to report quarterly earnings at $0.91 per share on revenue of $446.21 million.

    • 22nd Century Group (NASDAQ:XXII) is estimated to report quarterly loss at $0.06 per share on revenue of $11.32 million.

    • Establishment Labs Hldgs (NASDAQ:ESTA) is likely to report quarterly loss at $0.33 per share on revenue of $34.85 million.

    • Sotera Health (NASDAQ:SHC) is estimated to report quarterly earnings at $0.22 per share on revenue of $236.37 million.

    • Everi Holdings (NYSE:EVRI) is projected to report quarterly earnings at $0.36 per share on revenue of $167.48 million.

    • Telos (NASDAQ:TLS) is estimated to report quarterly earnings at $0.11 per share on revenue of $76.02 million.

    • Manchester United (NYSE:MANU) is projected to report quarterly earnings at $2.00 per share on revenue of $269.02 million.

    • Shift4 Payments (NYSE:FOUR) is estimated to report quarterly earnings at $0.18 per share on revenue of $382.86 million.

    • Wendy's (NASDAQ:WEN) is expected to report quarterly earnings at $0.15 per share on revenue of $460.45 million.

    • Rhythm Pharmaceuticals (NASDAQ:RYTM) is projected to report quarterly loss at $0.91 per share on revenue of $1.70 million.

    • Seres Therapeutics (NASDAQ:MCRB) is estimated to report quarterly loss at $0.44 per share on revenue of $12.25 million.

    • Kontoor Brands (NYSE:KTB) is likely to report quarterly earnings at $0.79 per share on revenue of $688.23 million.

    • Xenia Hotels & Resorts (NYSE:XHR) is likely to report quarterly loss at $0.19 per share on revenue of $181.51 million.

    • Bentley Systems (NASDAQ:BSY) is projected to report quarterly earnings at $0.17 per share on revenue of $262.45 million.

    • Novanta (NASDAQ:NOVT) is projected to report quarterly earnings at $0.64 per share on revenue of $191.62 million.

    • Hilton Grand Vacations (NYSE:HGV) is expected to report quarterly earnings at $0.88 per share on revenue of $856.93 million.

    • Axsome Therapeutics (NASDAQ:AXSM) is estimated to report earnings for its fourth quarter.

    • Chimerix (NASDAQ:CMRX) is expected to report quarterly loss at $0.17 per share on revenue of $17.55 million.

    • Renewable Energy Gr (NASDAQ:REGI) is estimated to report quarterly earnings at $0.82 per share on revenue of $799.27 million.

    • Albireo Pharma (NASDAQ:ALBO) is expected to report quarterly loss at $1.35 per share on revenue of $12.48 million.

    • Intra-Cellular Therapies (NASDAQ:ITCI) is estimated to report quarterly loss at $1.00 per share on revenue of $25.37 million.

    • Epizyme (NASDAQ:EPZM) is expected to report quarterly loss at $0.45 per share on revenue of $18.63 million.

    • Village Farms Intl (NASDAQ:VFF) is projected to report quarterly earnings at $0.01 per share on revenue of $70.08 million.

    • UWM Holdings (NYSE:UWMC) is likely to report quarterly earnings at $0.14 per share on revenue of $630.82 million.

    • Horizon Therapeutics (NASDAQ:HZNP) is projected to report quarterly earnings at $1.34 per share on revenue of $995.87 million.

    • Agenus (NASDAQ:AGEN) is likely to report quarterly loss at $0.16 per share on revenue of $37.74 million.

    • Nuwellis (NASDAQ:NUWE) is expected to report quarterly loss at $0.48 per share on revenue of $2.11 million.

    • Interface (NASDAQ:TILE) is projected to report quarterly earnings at $0.31 per share on revenue of $324.67 million.

    • Intl Game Tech (NYSE:IGT) is expected to report quarterly earnings at $0.49 per share on revenue of $1.02 billion.

    • L.B. Foster (NASDAQ:FSTR) is likely to report quarterly earnings at $0.19 per share on revenue of $132.48 million.

    • Amyris (NASDAQ:AMRS) is projected to report earnings for its fourth quarter.

    • TriMas (NASDAQ:TRS) is expected to report quarterly earnings at $0.53 per share on revenue of $209.49 million.

    • Terminix Global Hldgs (NYSE:TMX) is projected to report quarterly earnings at $0.22 per share on revenue of $482.57 million.

    • Acushnet Holdings (NYSE:GOLF) is estimated to report quarterly loss at $0.29 per share on revenue of $380.65 million.

    • Studio City Intl Hldgs (NYSE:MSC) is estimated to report earnings for its fourth quarter.

    • Federal Signal (NYSE:FSS) is likely to report quarterly earnings at $0.38 per share on revenue of $301.67 million.

    • Domino's Pizza (NYSE:DPZ) is estimated to report quarterly earnings at $4.28 per share on revenue of $1.38 billion.

    • eHealth (NASDAQ:EHTH) is likely to report quarterly earnings at $0.94 per share on revenue of $251.76 million.

    • Veritiv (NYSE:VRTV) is likely to report quarterly earnings at $2.66 per share on revenue of $1.72 billion.

    • Sea (NYSE:SE) is projected to report quarterly loss at $0.59 per share on revenue of $2.91 billion.

    • Chico's FAS (NYSE:CHS) is likely to report quarterly earnings at $0.05 per share on revenue of $498.70 million.

    • Perrigo (NYSE:PRGO) is projected to report quarterly earnings at $0.56 per share on revenue of $1.10 billion.

    • Builders FirstSource (NYSE:BLDR) is estimated to report quarterly earnings at $1.91 per share on revenue of $4.29 billion.

    • JM Smucker (NYSE:SJM) is projected to report quarterly earnings at $2.09 per share on revenue of $2.04 billion.

    • Amarin Corp (NASDAQ:AMRN) is likely to report quarterly loss at $0.02 per share on revenue of $141.75 million.

    • Akebia Therapeutics (NASDAQ:AKBA) is estimated to report quarterly loss at $0.33 per share on revenue of $50.80 million.

    • ADT (NYSE:ADT) is estimated to report quarterly earnings at $0.19 per share on revenue of $1.32 billion.

    • iQIYI (NASDAQ:IQ) is projected to report quarterly loss at $0.32 per share on revenue of $1.15 billion.

    • Target (NYSE:TGT) is likely to report quarterly earnings at $2.86 per share on revenue of $31.41 billion.

     

    Companies Reporting After The Bell

    • Meta Materials (NASDAQ:MMAT) is estimated to report earnings for its fourth quarter.

    • Rocky Brands (NASDAQ:RCKY) is expected to report earnings for its fourth quarter.

    • ClearPoint Neuro (NASDAQ:CLPT) is projected to report quarterly loss at $0.19 per share on revenue of $4.30 million.

    • ContextLogic (NASDAQ:WISH) is projected to report quarterly loss at $0.09 per share on revenue of $313.47 million.

    • Celsius Holdings (NASDAQ:CELH) is estimated to report quarterly earnings at $0.04 per share on revenue of $92.09 million.

    • Neoleukin Therapeutics (NASDAQ:NLTX) is likely to report earnings for its fourth quarter.

    • Hydrofarm Holdings Group (NASDAQ:HYFM) is estimated to report quarterly earnings at $0.03 per share on revenue of $108.33 million.

    • Omeros (NASDAQ:OMER) is likely to report quarterly loss at $0.36 per share on revenue of $30.86 million.

    • Antero Resources (NYSE:AR) is expected to report quarterly earnings at $0.07 per share on revenue of $142.62 million.

    • Vector Group (NYSE:VGR) is expected to report quarterly earnings at $0.43 per share on revenue of $612.20 million.

    • Bionano Genomics (NASDAQ:BNGO) is projected to report quarterly loss at $0.06 per share on revenue of $5.57 million.

    • ChemoCentryx (NASDAQ:CCXI) is estimated to report quarterly loss at $0.50 per share on revenue of $11.62 million.

    • Plug Power (NASDAQ:PLUG) is estimated to report quarterly loss at $0.11 per share on revenue of $157.32 million.

    • Southwest Gas Holdings (NYSE:SWX) is projected to report quarterly earnings at $1.57 per share on revenue of $1.01 billion.

    • Syndax Pharmaceuticals (NASDAQ:SNDX) is estimated to report quarterly earnings at $0.28 per share on revenue of $58.68 million.

    • AMC Entertainment (NYSE:AMC) is projected to report quarterly loss at $0.26 per share on revenue of $1.09 billion.

    • Regenxbio (NASDAQ:RGNX) is likely to report quarterly earnings at $4.71 per share on revenue of $271.74 million.

    • Xenon Pharmaceuticals (NASDAQ:XENE) is likely to report quarterly loss at $0.37 per share on revenue of $4.97 million.

    • Sarepta Therapeutics (NASDAQ:SRPT) is projected to report quarterly loss at $1.13 per share on revenue of $198.61 million.

    • Nextdoor Holdings (NYSE:KIND) is likely to report quarterly loss at $0.04 per share on revenue of $55.37 million.

    • a.k.a. Brands Holding (NYSE:AKA) is expected to report quarterly earnings at $0.03 per share on revenue of $177.66 million.

    • ForgeRock (NYSE:FORG) is projected to report quarterly loss at $0.13 per share on revenue of $46.79 million.

    • Dutch Bros (NYSE:BROS) is expected to report quarterly earnings at $0.02 per share on revenue of $135.00 million.

    • Beachbody (NYSE:BODY) is expected to report quarterly loss at $0.19 per share on revenue of $167.94 million.

    • 1stdibs.com (NASDAQ:DIBS) is likely to report quarterly loss at $0.17 per share on revenue of $26.97 million.

    • Proterra (NASDAQ:PTRA) is estimated to report quarterly loss at $0.16 per share on revenue of $67.23 million.

    • ZipRecruiter (NYSE:ZIP) is estimated to report quarterly earnings at $0.12 per share on revenue of $207.08 million.

    • SoFi Technologies (NASDAQ:SOFI) is projected to report quarterly loss at $0.17 per share on revenue of $279.29 million.

    • Zai Lab (NASDAQ:ZLAB) is expected to report quarterly loss at $1.65 per share on revenue of $36.91 million.

    • XL Fleet (NYSE:XL) is projected to report quarterly loss at $0.11 per share on revenue of $5.20 million.

    • Ideanomics (NASDAQ:IDEX) is likely to report quarterly loss at $0.05 per share on revenue of $33.20 million.

    • Romeo Power (NYSE:RMO) is projected to report quarterly loss at $0.21 per share on revenue of $7.30 million.

    • Porch Group (NASDAQ:PRCH) is likely to report quarterly loss at $0.21 per share on revenue of $54.64 million.

    • PLBY Group (NASDAQ:PLBY) is likely to report quarterly earnings at $0.10 per share on revenue of $84.35 million.

    • GrowGeneration (NASDAQ:GRWG) is expected to report quarterly loss at $0.09 per share on revenue of $89.09 million.

    • BTRS Holdings (NASDAQ:BTRS) is estimated to report quarterly loss at $0.08 per share on revenue of $33.08 million.

    • Organogenesis Holdings (NASDAQ:ORGO) is projected to report quarterly earnings at $0.08 per share on revenue of $124.70 million.

    • Advantage Solutions (NASDAQ:ADV) is likely to report quarterly earnings at $0.22 per share on revenue of $952.99 million.

    • Vuzix (NASDAQ:VUZI) is estimated to report quarterly loss at $0.12 per share on revenue of $3.97 million.

    • PAR Technology (NYSE:PAR) is expected to report quarterly loss at $0.38 per share on revenue of $76.02 million.

    • BRP Group (NASDAQ:BRP) is likely to report quarterly earnings at $0.09 per share on revenue of $142.27 million.

    • Domo (NASDAQ:DOMO) is projected to report quarterly loss at $0.39 per share on revenue of $67.09 million.

    • Green Brick Partners (NYSE:GRBK) is estimated to report quarterly earnings at $1.16 per share on revenue of $405.92 million.

    • Senseonics Holdings (AMEX:SENS) is projected to report quarterly loss at $0.03 per share on revenue of $3.98 million.

    • Stellus Cap Investment (NYSE:SCM) is projected to report quarterly earnings at $0.28 per share on revenue of $16.41 million.

    • Jamf Holding (NASDAQ:JAMF) is estimated to report quarterly earnings at $0.01 per share on revenue of $100.29 million.

    • DermTech (NASDAQ:DMTK) is likely to report quarterly loss at $0.73 per share on revenue of $3.40 million.

    • Certara (NASDAQ:CERT) is projected to report quarterly earnings at $0.08 per share on revenue of $83.26 million.

    • Rigel Pharmaceuticals (NASDAQ:RIGL) is projected to report quarterly loss at $0.13 per share on revenue of $21.90 million.

    • Mayville Engineering (NYSE:MEC) is projected to report quarterly loss at $0.01 per share on revenue of $110.18 million.

    • Horizon Tech Finance (NASDAQ:HRZN) is likely to report quarterly earnings at $0.35 per share on revenue of $16.13 million.

    • Grocery Outlet Holding (NASDAQ:GO) is expected to report quarterly earnings at $0.20 per share on revenue of $778.40 million.

    • Fabrinet (NYSE:FN) is likely to report quarterly earnings at $0.82 per share on revenue of $181.30 million.

    • Scientific Games (NASDAQ:SGMS) is projected to report quarterly earnings at $0.13 per share on revenue of $558.56 million.

    • SciPlay (NASDAQ:SCPL) is likely to report quarterly earnings at $0.23 per share on revenue of $153.86 million.

    • Repay Holdings (NASDAQ:RPAY) is estimated to report quarterly earnings at $0.20 per share on revenue of $63.56 million.

    • Cara Therapeutics (NASDAQ:CARA) is projected to report quarterly loss at $0.52 per share on revenue of $1.46 million.

    • NanoString Technologies (NASDAQ:NSTG) is estimated to report quarterly loss at $0.59 per share on revenue of $41.47 million.

    • Inovio Pharmaceuticals (NASDAQ:INO) is projected to report quarterly loss at $0.32 per share on revenue of $2.84 million.

    • Cardlytics (NASDAQ:CDLX) is estimated to report quarterly loss at $0.42 per share on revenue of $76.58 million.

    • Recro Pharma (NASDAQ:REPH) is expected to report quarterly loss at $0.07 per share on revenue of $21.41 million.

    • Health Catalyst (NASDAQ:HCAT) is expected to report quarterly loss at $0.21 per share on revenue of $63.14 million.

    • PetIQ (NASDAQ:PETQ) is likely to report quarterly earnings at $0.02 per share on revenue of $169.68 million.

    • Colfax (NYSE:CFX) is likely to report quarterly loss at $0.27 per share on revenue of $240.00 million.

    • Alexandria Real Estate (NYSE:ARE) is projected to report quarterly earnings at $0.47 per share on revenue of $1.14 billion.

    • Whitestone REIT (NYSE:WSR) is expected to report quarterly earnings at $0.06 per share on revenue of $32.67 million.

    • SLR Senior Investment (NASDAQ:SUNS) is expected to report quarterly earnings at $0.29 per share on revenue of $8.25 million.

    • SLR Investment (NASDAQ:SLRC) is projected to report quarterly earnings at $0.38 per share on revenue of $37.39 million.

    • Ecopetrol (NYSE:EC) is projected to report quarterly earnings at $0.57 per share on revenue of $6.42 billion.

    • Aware (NASDAQ:AWRE) is estimated to report quarterly loss at $0.10 per share on revenue of $3.70 million.

    • CarParts.com (NASDAQ:PRTS) is expected to report quarterly loss at $0.11 per share on revenue of $133.34 million.

    • Benefitfocus (NASDAQ:BNFT) is estimated to report quarterly earnings at $0.07 per share on revenue of $70.00 million.

    • Inseego (NASDAQ:INSG) is likely to report quarterly loss at $0.06 per share on revenue of $71.19 million.

    • CytomX Therapeutics (NASDAQ:CTMX) is likely to report quarterly loss at $0.28 per share on revenue of $24.51 million.

    • Apartment Investment (NYSE:AIV) is projected to report earnings for its fourth quarter.

    • Alphatec Holdings (NASDAQ:ATEC) is likely to report quarterly loss at $0.31 per share on revenue of $69.40 million.

    • Urban Outfitters (NASDAQ:URBN) is estimated to report quarterly earnings at $0.50 per share on revenue of $1.33 billion.

    • Ross Stores (NASDAQ:ROST) is estimated to report quarterly earnings at $0.98 per share on revenue of $4.97 billion.

    • B&G Foods (NYSE:BGS) is likely to report quarterly earnings at $0.43 per share on revenue of $591.56 million.

    • Big 5 Sporting Goods (NASDAQ:BGFV) is expected to report quarterly earnings at $0.85 per share on revenue of $273.40 million.

    • TTEC Holdings (NASDAQ:TTEC) is likely to report quarterly earnings at $1.03 per share on revenue of $593.66 million.

    • Inter Parfums (NASDAQ:IPAR) is estimated to report quarterly loss at $0.20 per share on revenue of $210.80 million.

    • Arlo Technologies (NYSE:ARLO) is expected to report quarterly loss at $0.03 per share on revenue of $134.94 million.

    • Avid Technology (NASDAQ:AVID) is expected to report quarterly earnings at $0.42 per share on revenue of $111.18 million.

    • Nordstrom (NYSE:JWN) is likely to report quarterly earnings at $1.02 per share on revenue of $4.35 billion.

    • WW International (NASDAQ:WW) is likely to report quarterly earnings at $0.36 per share on revenue of $279.29 million.

    • Jazz Pharmaceuticals (NASDAQ:JAZZ) is estimated to report quarterly earnings at $3.63 per share on revenue of $865.88 million.

    • Hewlett Packard (NYSE:HPE) is projected to report quarterly earnings at $0.46 per share on revenue of $7.03 billion.

    • First Solar (NASDAQ:FSLR) is estimated to report quarterly earnings at $1.06 per share on revenue of $917.69 million.

    • Salesforce.com (NYSE:CRM) is expected to report quarterly earnings at $0.75 per share on revenue of $7.24 billion.

    • Cornerstone Building (NYSE:CNR) is estimated to report quarterly earnings at $0.57 per share on revenue of $1.45 billion.

    This article was generated by Benzinga's automated content engine and reviewed by an editor.

    Get the next $ADT alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ADT
    $ADV
    $AGEN
    $AIV

    CompanyDatePrice TargetRatingAnalyst
    Certara Inc.
    $CERT
    2/27/2026$10.00Buy → Hold
    Craig Hallum
    Target Corporation
    $TGT
    2/27/2026$103.00Underperform
    BofA Securities
    Jazz Pharmaceuticals plc
    $JAZZ
    2/27/2026$224.00Overweight
    Barclays
    Celsius Holdings Inc.
    $CELH
    2/27/2026$65.00Underperform → Buy
    BofA Securities
    Federal Signal Corporation
    $FSS
    2/26/2026$140.00Market Perform → Market Outperform
    CJS Securities
    eHealth Inc.
    $EHTH
    2/26/2026$2.00Buy → Hold
    Craig Hallum
    Builders FirstSource Inc.
    $BLDR
    2/26/2026Outperform
    William Blair
    First Solar Inc.
    $FSLR
    2/26/2026$245.00Buy → Hold
    Deutsche Bank
    More analyst ratings

    $ADT
    $ADV
    $AGEN
    $AIV
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Certara downgraded by Craig Hallum with a new price target

    Craig Hallum downgraded Certara from Buy to Hold and set a new price target of $10.00

    2/27/26 8:32:38 AM ET
    $CERT
    Computer Software: Prepackaged Software
    Technology

    BofA Securities resumed coverage on Target with a new price target

    BofA Securities resumed coverage of Target with a rating of Underperform and set a new price target of $103.00

    2/27/26 8:32:12 AM ET
    $TGT
    Department/Specialty Retail Stores
    Consumer Discretionary

    Barclays initiated coverage on Jazz Pharma with a new price target

    Barclays initiated coverage of Jazz Pharma with a rating of Overweight and set a new price target of $224.00

    2/27/26 8:31:30 AM ET
    $JAZZ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADT
    $ADV
    $AGEN
    $AIV
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Executive Chairman Marcus Joel S bought $1,347,889 worth of shares (25,000 units at $53.92), increasing direct ownership by 5% to 562,724 units (SEC Form 4)

    4 - ALEXANDRIA REAL ESTATE EQUITIES, INC. (0001035443) (Issuer)

    2/13/26 4:45:00 PM ET
    $ARE
    Real Estate Investment Trusts
    Real Estate

    General Counsel Lavet Robert S bought $105,220 worth of shares (5,000 units at $21.04) (SEC Form 4)

    4 - SoFi Technologies, Inc. (0001818874) (Issuer)

    2/6/26 6:18:51 PM ET
    $SOFI
    Finance: Consumer Services
    Finance

    EVP GBUL Borrow Schuppenhauer Eric bought $99,650 worth of shares (5,000 units at $19.93), increasing direct ownership by 2% to 228,768 units (SEC Form 4)

    4 - SoFi Technologies, Inc. (0001818874) (Issuer)

    2/5/26 5:53:28 PM ET
    $SOFI
    Finance: Consumer Services
    Finance

    $ADT
    $ADV
    $AGEN
    $AIV
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for REVUFORJ issued to SYNDAX PHARMACEUTICALS INC

    Submission status for SYNDAX PHARMACEUTICALS INC's drug REVUFORJ (ORIG-1) with active ingredient REVUMENIB has changed to 'Approval' on 11/15/2024. Application Category: NDA, Application Number: 218944, Application Classification: Type 1 - New Molecular Entity

    11/18/24 9:22:42 AM ET
    $SNDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    November 14, 2024 - FDA Approves First Gene Therapy for Treatment of Aromatic L-amino Acid Decarboxylase Deficiency

    For Immediate Release: November 14, 2024 The U.S. Food and Drug Administration approved Kebilidi (eladocagene exuparvovec-tneq), an adeno-associated virus vector-based gene therapy indicated for the treatment of adult and pediatric patients with aromatic L-amino acid decarboxylase (AADC) deficiency. Kebilidi is the first FDA-approved gene therapy for treatment of AADC deficiency. “Clinical advancements in the f

    11/14/24 8:50:18 AM ET
    $CLPT
    $PTCT
    Medical/Dental Instruments
    Health Care
    Biotechnology: Pharmaceutical Preparations

    FDA Approval for BRIUMVI issued to TG THERAPEUTICS, INC

    Submission status for TG THERAPEUTICS, INC's drug BRIUMVI (SUPPL-11) with active ingredient UBLITUXIMAB-XIIY has changed to 'Approval' on 10/30/2024. Application Category: BLA, Application Number: 761238, Application Classification:

    10/31/24 4:38:40 AM ET
    $TGTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADT
    $ADV
    $AGEN
    $AIV
    SEC Filings

    View All

    SEC Form FWP filed by Bank Of Montreal

    FWP - BANK OF MONTREAL /CAN/ (0000927971) (Subject)

    2/27/26 5:14:44 PM ET
    $BMO
    Commercial Banks
    Finance

    SEC Form FWP filed by Bank Of Montreal

    FWP - BANK OF MONTREAL /CAN/ (0000927971) (Subject)

    2/27/26 5:14:44 PM ET
    $BMO
    Commercial Banks
    Finance

    SEC Form FWP filed by Bank Of Montreal

    FWP - BANK OF MONTREAL /CAN/ (0000927971) (Subject)

    2/27/26 5:12:49 PM ET
    $BMO
    Commercial Banks
    Finance

    $ADT
    $ADV
    $AGEN
    $AIV
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    ADT Announces Grants of Inducement Equity Awards

    BOCA RATON, Fla., Feb. 27, 2026 (GLOBE NEWSWIRE) -- ADT Inc. (NYSE:ADT) today announced that its board of directors has approved the grant of equity awards in connection with ADT's acquisition of Origin Wireless, Inc., a privately held company that specializes in AI-enabled WiFi sensing technology ("Origin"), in reliance on the employment inducement awards exemption under the NYSE's Listed Company Manual Rule 303A.08. The board approved the grant of equity awards representing 8,070,357 shares of ADT common stock in the form of restricted stock units to 46 Origin employees who became ADT employees upon the closing of the acquisition. The board approved these awards to aid in the retention

    2/27/26 4:15:00 PM ET
    $ADT
    Diversified Commercial Services
    Consumer Discretionary

    Weight Watchers Schedules Fourth Quarter and Full Year 2025 Earnings Conference Call

    NEW YORK, Feb. 27, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ:WW) ("Weight Watchers" or the "Company") will release its results for the fourth quarter and full year 2025 ended December 31, 2025 before market open on Monday, March 16, 2026. Weight Watchers will host a conference call to discuss results at 8:30 a.m. ET the same day. The webcast of the conference call will be available on the Company's corporate website, corporate.ww.com, under Events and Presentations. A replay of the webcast will be available on this site for at least 90 days. About Weight WatchersWeight Watchers is the global leader in science-backed weight management, offering an integrated support system b

    2/27/26 4:01:00 PM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    Vuzix Schedules Conference Call to Discuss Fourth Quarter and Full Year 2025 Financial Results and Business Update

    ROCHESTER, N.Y., Feb. 27, 2026 /PRNewswire/ -- Vuzix® Corporation (NASDAQ:VUZI), ("Vuzix" or, the "Company"), a leading supplier of smart glasses and Augmented Reality (AR) technology and products, is pleased to announce that the Company will host a conference call regarding its fourth quarter and full year 2025 operating results on Thursday, March 12, 2026 at 4:30 PM Eastern Time (ET). To join the live conference call, please dial 877-709-8150 (U.S. and Canadian callers) or 201-689-8354 (international callers outside of the U.S. and Canada) 10 to 15 minutes prior to the schedul

    2/27/26 3:00:00 PM ET
    $VUZI
    Radio And Television Broadcasting And Communications Equipment
    Technology

    $ADT
    $ADV
    $AGEN
    $AIV
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP, SALES Sponsel David was granted 318,884 shares, increasing direct ownership by 91% to 668,384 units (SEC Form 4)

    4 - Alphatec Holdings, Inc. (0001350653) (Issuer)

    2/27/26 9:30:15 PM ET
    $ATEC
    Medical/Dental Instruments
    Health Care

    GENERAL COUNSEL & CORP. SEC. Marshall Tyson Eliot was granted 302,852 shares, increasing direct ownership by 88% to 648,294 units (SEC Form 4)

    4 - Alphatec Holdings, Inc. (0001350653) (Issuer)

    2/27/26 9:30:17 PM ET
    $ATEC
    Medical/Dental Instruments
    Health Care

    CHIEF FINANCIAL OFFICER Koning John Todd was granted 335,868 shares, increasing direct ownership by 81% to 749,420 units (SEC Form 4)

    4 - Alphatec Holdings, Inc. (0001350653) (Issuer)

    2/27/26 9:30:11 PM ET
    $ATEC
    Medical/Dental Instruments
    Health Care

    $ADT
    $ADV
    $AGEN
    $AIV
    Leadership Updates

    Live Leadership Updates

    View All

    Bionano Symposium 2026 Concluded with 9 Speakers Describing the Breadth of Bionano Solutions and Their Potential for Use on a Large Scale

    SAN DIEGO, Feb. 27, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ:BNGO) today announced highlights from the fourth and final day of Symposium 2026. Day 4 featured updates from some of the most advanced and high-volume cytogenetics and molecular pathology laboratories in the United States, Canada and Europe describing how they envision scaling optical genome mapping (OGM), including processing up to thousands of samples per year with automation, multiple OGM systems, and VIA™ software. Other talks covered topics like Bionano's Ionic® system for isolating DNA and RNA for next generation sequencing (NGS) and advanced analytical tools that could be the future of digital cytogenetics

    2/27/26 8:00:00 AM ET
    $BNGO
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Federal Signal Corporation Appoints Two New Directors

    DOWNERS GROVE, Ill., Feb. 26, 2026 /PRNewswire/ -- The Board of Directors of Federal Signal Corporation (NYSE: FSS) ("Federal Signal" or the "Company"), a leader in environmental and safety solutions, today announced the appointments of Richard ("Rich") A. Maue and Eric A. Vaillancourt to the Company's board of directors, effective immediately. "We are delighted to announce the appointments of Rich and Eric to our board of directors," said Brenda L. Reichelderfer, Chair of the board of Federal Signal. "Rich's vast experience as a senior finance leader in a global industrial organization, currently as the Chief Financial Officer ("CFO"), positions him to provide immediate, valued insight to o

    2/26/26 4:00:00 PM ET
    $CR
    $FSS
    $NPO
    Metal Fabrications
    Industrials
    Auto Manufacturing

    Playboy Appoints David Miller as President, Media & Brand

    Media Veteran Miller to Oversee Global Licensing, Digital and Platform Growth Senior Appointment Reflects Playboy's Accelerating Growth Strategy and Expanding Media and Licensing Operations LOS ANGELES, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Playboy, Inc. (NASDAQ:PLBY) ("Playboy" or the "Company"), a global pleasure and leisure company, has announced that David Miller has been appointed President, Media & Brand, to drive the next phase of the Company's growth. Miller joins Playboy from The Walt Disney Company, where he served as Executive Vice President and General Manager of National Geographic Media, with full P&L responsibility across global editorial, digital, print, and social operation

    2/26/26 8:31:00 AM ET
    $PLBY
    Other Specialty Stores
    Consumer Discretionary

    $ADT
    $ADV
    $AGEN
    $AIV
    Financials

    Live finance-specific insights

    View All

    Weight Watchers Schedules Fourth Quarter and Full Year 2025 Earnings Conference Call

    NEW YORK, Feb. 27, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ:WW) ("Weight Watchers" or the "Company") will release its results for the fourth quarter and full year 2025 ended December 31, 2025 before market open on Monday, March 16, 2026. Weight Watchers will host a conference call to discuss results at 8:30 a.m. ET the same day. The webcast of the conference call will be available on the Company's corporate website, corporate.ww.com, under Events and Presentations. A replay of the webcast will be available on this site for at least 90 days. About Weight WatchersWeight Watchers is the global leader in science-backed weight management, offering an integrated support system b

    2/27/26 4:01:00 PM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    Vuzix Schedules Conference Call to Discuss Fourth Quarter and Full Year 2025 Financial Results and Business Update

    ROCHESTER, N.Y., Feb. 27, 2026 /PRNewswire/ -- Vuzix® Corporation (NASDAQ:VUZI), ("Vuzix" or, the "Company"), a leading supplier of smart glasses and Augmented Reality (AR) technology and products, is pleased to announce that the Company will host a conference call regarding its fourth quarter and full year 2025 operating results on Thursday, March 12, 2026 at 4:30 PM Eastern Time (ET). To join the live conference call, please dial 877-709-8150 (U.S. and Canadian callers) or 201-689-8354 (international callers outside of the U.S. and Canada) 10 to 15 minutes prior to the schedul

    2/27/26 3:00:00 PM ET
    $VUZI
    Radio And Television Broadcasting And Communications Equipment
    Technology

    Federal Signal Corporation Increases Quarterly Dividend by 7%

    DOWNERS GROVE, Ill., Feb. 27, 2026 /PRNewswire/ -- The Board of Directors of Federal Signal Corporation (NYSE:FSS) declared a quarterly cash dividend of fifteen cents ($0.15) per share on its common stock. This represents an increase of $0.01 per share, or 7%, compared to the dividend declared in the prior quarter. The dividend is payable on March 26, 2026 to stockholders of record at the close of business on March 13, 2026. About Federal SignalFederal Signal Corporation (NYSE:FSS) builds and delivers equipment of unmatched quality that moves material, cleans infrastructure, and protects the communities where we work and live. Founded in 1901, Federal Signal is a leading global designer, man

    2/27/26 9:15:00 AM ET
    $FSS
    Auto Manufacturing
    Industrials

    $ADT
    $ADV
    $AGEN
    $AIV
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Pieris Pharmaceuticals Inc.

    SC 13G/A - PALVELLA THERAPEUTICS, INC. (0001583648) (Subject)

    12/17/24 5:42:35 PM ET
    $PIRS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13D/A filed by P10 Inc.

    SC 13D/A - P10, Inc. (0001841968) (Subject)

    12/13/24 9:00:20 PM ET
    $PX
    Investment Managers
    Finance

    SEC Form SC 13D filed by First Solar Inc.

    SC 13D - FIRST SOLAR, INC. (0001274494) (Subject)

    12/10/24 1:11:10 PM ET
    $FSLR
    Semiconductors
    Technology